Scientists test Triple-Threat treatment to shrink tumors before surgery
Disease control
Recruiting now
This study is testing a new combination treatment for people with stage III stomach or gastroesophageal junction cancer. The goal is to see if giving immunotherapy (Serplulimab), an immune-boosting drug (thymalfasin), and standard chemotherapy (SOX) before surgery can shrink tumo…
Phase: PHASE2 • Sponsor: Zekuan Xu • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC